Anbio Tech - NNNN Net earnings per share for the last four quarters

Anbio Biotechnology Ltd (NNNN) - corporate logo

Anbio Biotechnology profitability relies on its own plants in China, where sterility ensures test stability. Comparable annual EPS TTM growth visualizes profit dynamics, with the latest parameter standing at 169.40. Intense competition for diagnostic speed against industry behemoths and startups increases pressure. The company is currently optimizing factory costs, adapting to the normalization of demand following periods of hype.

NNNN Anbio Biotechnology: Net earnings per share (EPS TTM) in the range 11/23/2025 - 11/16/2026

Anbio Biotechnology - analytical breakdowns and key metrics (NNNN)

- market price and analyst price targets:
Fundamental company valuation:NNNN (Anbio Biotechnology Ltd)
Finished products of Anbio Corp

To filter for high-quality assets, investors utilize profit growth analysis to avoid capital stagnation during market cycle shifts. This indicator measures the percentage increase in net income per share over a rolling year, reflecting the efficiency of Anbio Biotechnology (NNNN) in outsourcing reagent production, which is clearly evidenced by the rolling year EPS percentage change trend.

Competitor analysis

A - Net earnings per share (EPS TTM)|Quest Corp (DGX) - Earnings per share for the last twelve months|ILMN - Net earnings per share for the last four quarters|Earnings per share for the last twelve months exactsciences.com|revvity.com (RVTY) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) BIO|SHC - Net earnings per one share for the last twelve months|Quidel Corporation - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) OPKO Health Corp. OPK|CDNA - Earnings per share for the last twelve months|Earnings per share for the trailing year MRVI (Maravai LifeSciences)|FLGT: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months LAB|Earnings per share for the last twelve months Cytek Biosciences Inc|Net earnings per share (EPS TTM) OraSure Corp|Net earnings per share for the last 12 months XGN (Exagen Inc)|Net earnings per share (EPS TTM) mdxhealth.com (MDXH)|Net earnings per share (EPS TTM) LUCD (Lucid Diagnostics Inc)|PRE - Net earnings per share for the last 12 months|IMDX: Net earnings per share for the last 12 months|Earnings per share for the trailing year TRIB (trinitybiotech.com)|PRPH (ProPhase Labs, Inc.) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Ainos|Earnings per share for the last twelve months Co-Diagnostics Inc|HSCS (Heart Test Laboratories Inc.) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) BMRA|Cardio Diagnostics Holdings Inc. (CDIO) - Net earnings per share for the trailing year|Earnings per share for the last twelve months Onconetix ONCO|viraxbiolabs.com - Earnings per share for the last twelve months|BJDX - Earnings per share for the last twelve months|Earnings per share for the trailing year AWH (Aspira Women's Health Inc.)|AXDX: Net earnings per share (EPS TTM)|CNTG - Net earnings per share for the last four quarters|ENZ (enzo.com) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months FRES|Earnings per share for the last twelve months Genetic Technologies (GENE)|Net earnings per share for the last four quarters 23andMe Holding Co|Net earnings per share (EPS TTM) PMD (Psychemedics)